| 1Tang ZY,Ye SL,Liu YK,et al,Adecade’s studies on metastasis of hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2004,130(4):187-196.
2Makoto,K,Takashi K,Takeshi S,et al.Fucosylated fraction of alpha-fetoprotein,L3,as a useful prognostic factor in patients with hepatocellular carcinoma with spe-cial reference to lowconcentrations of serum alpha-fetoprotein[J].Hepatology Re-search,2007,37(11):914-922.
3Xiang D,Lian YY,Geng WH,et al.Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma:A sys-tematic review and meta-analysis[J].World J Gastroenterol,2005,11(17):2656-61.
4刘树林,齐为民,李斌,等.甲胎蛋白生物半衰期与肝癌复发转移的关系[J].免疫学杂志,2001,17(2):135-137.
5易述红,陈规划,陆敏强,等.VEGF mRNA在预测肝癌肝移植术后肿瘤复发和转移中的应用价值[J].中国普外基础与临床杂志,2006,13(5):560-563,572.
6赵秀兰,杜静,赵学铭,等.VEGF和MMP-2表达与肝细胞肝癌复发和预后的关系[J].中国肿瘤临床,2008,35(16):934-937.
7孟春城,陈孝平.VEGF、u-PA、ICAM-1和PCNA蛋白质表达与肝癌转移复发的关系[J].中华外科杂志,2002,40(9):673-675.
8Zhang Q,Chen X,Zhou J,et al.CD147,MMP-2,MMP-9and MVD-CD34are sig-nificant predictors of recurrence after liver transplantation in hepatocellular carcino-ma patients[J].Cancer Biol Ther,2006,5(7):808-814.
9Mei MH,Xu J,Shi QF,et a1.Clinical significance of serum intercellular adhesion molecule-l detection in patients with hepatocellular carcinoma[J].World J Gastro-enterol,2000,6(3):408-410.
10张辉,任宁,叶青海,等.联合检测血浆骨桥蛋白和细胞间黏附分子对预测肝细胞癌患者术后预后的价值[J].中华外科杂志,2005,43(15):985-988.
11Liu YB,Gao SL,Chen XP,et a1.Expression and significance of heparanase andnm23-H1in hepatocellular carcinoma[J].World J Gastroenterol,2005,11(9):1378-1381.
12罗志强,刘锋,邵江华,等.原发性肝癌组织中肝素酶表达与肝癌侵袭转移关系的研究[J].浙江临床医学,2008,1O(12):1560-1563.
13王文清,邱双键,吴志全,等.肝细胞癌根治性切除术后复发转移与血清转化生长因子-β1的关系[J].中国实验外科杂志,2005,22(1):100-101.
14Shi YZ,Hui AM,Takayama T,et a1.Reduced p21(WAFI/CIP1)protein expres-sion is predominantly related to altered p53in hepatocellular carcinoma[J].Br J Cancer,2000,83(1):50-55.
15Wang Y,Wu MC,Sham JS,et a1.Prognostic significance of c-myc and AIB1am-plification in hepatocellular carcinoma:A broad survey using high-throughput tis-sue microarray[J].Cancer,2002,95(11):2346-2352.
16刘鹏飞,吴孟超,陈汉,等.原发性肝癌血液CD44v mRNA检测的临床意义[J].中华肝脏病杂志,1998,6(3):141-143.
17Mou DC,Cai SL,Peng JR,et a1.Evaluation of MAGE-1and MAGE-3as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells[J].British Journal of Cancer,2002,86(1):110-116.
18Sheen I,Jeng KS,Wu JY.Is p53gene mutation an indicatior of the biological be-haviors of recurrence of hepatocellular carcinoma-[J].World J Gastroenterol,2003,9(6):1202-1207.
19陈连周,夏金堂,李雯,等.PTEN和MMP-2表达与肝细胞肝癌生长、侵袭及转移[J].中华临床医师杂志(电子版),2008,2(11):1248-1253.
20宋丽杰,叶胜龙,王凯峰,等.DLC-1基因表达与肝细胞癌复发转移的关系[J].中华肝脏病杂志,2005,13,(6):428-431.
21Pan HW,Ou YH,Peng SY,et a1.Overexpression of osteopontin is associated with intrahepatic metastasis,early recurrence,and poorer prognosis of surgically resec-ted hepatocellular carcinoma[J].Cancer,2003,98(1):l19-127.
22Joo M,Chi JG,Lee H.Expressions of HSP70and HSP27in Hepatocellular Carci-noma[J].J Korean Med Sci,2005,2O(5):829-834.
23宋海燕,刘银坤,崔杰峰,等.人肝细胞性肝癌组织转移相关分子的比较蛋白质组学研究[J].中华肝脏病杂志,2005,13(5):331.
24王辉,韩亮,李庆友.E-钙黏素和γ-连环素与原发性肝癌侵袭转移的关系[J].腹部外科,2004,17(6):370.
25王晓明,王学浩,陈兆雷,等.p53及PCNA与小肝癌根治切除术后早期复发的相关性研究[J].武警医学,2005,16,(4):254-256.
26Kobayashi T,Kubota K,Takayama T,et al.Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy[J].Am J Surg,2001,181(3):284.
27Yao DF,Wu XH,Zhu Y,etal.Quantitative analysis of vascular endothelial growth factor,microvascular density and their clinicopathologic features in human hepato-cellular carcinoma[J].Hepatobiliary Pancreat Dis Int,2005,4(2):220-226.
28Dong ZZ,Yao DF,Yao DB,et a1.Expression and alteration of insulin-like growth factorⅡ-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma[J].World J Gastroenterol,2005,11(30):4655-4660.
29潘一明,姚永忠,朱章华,等.Caveolin-1在肝细胞性肝癌中的表达及其与肿瘤进展和预后的关系[J].现代医学,2008,36(6):385-388.
30许丽,吴一迁,金晏,等.DNA修复基因XPD多态性和肝细胞肝癌危险性的病例-对照研究[J].肿瘤,2004,24(6):526-529. |
